BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao X, Zheng YZ, Liao HY, Guo X, Li Y, Wang Z, Zhang L, Wang XD, Wang X. A clinical nomogram and heat map for assessing survival in patients with stage I non-small cell lung cancer after complete resection. Ther Adv Med Oncol 2020;12:1758835920970063. [PMID: 33224277 DOI: 10.1177/1758835920970063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye X, Liu Y, Yang J, Wang Y, Cui X, Xie H, Song L, Ding Z, Zhai R, Han Y, Yang L, Zhang H. Do older patients with stage IB non-small-cell lung cancer obtain survival benefits from surgery? A propensity score matching study using SEER data. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.03.015] [Reference Citation Analysis]
2 Yan C, Tu Z, Zhang Z, Ouyang X, Li D, Peng S, Zhong J. Institutionally validated nomogram predicting prognosis for older patients with nonmetastatic nasopharyngeal carcinoma. Future Oncol 2022. [PMID: 35179075 DOI: 10.2217/fon-2021-1121] [Reference Citation Analysis]
3 Chen H, Jiang Y, Jia K, Zhang K, Matsuura N, Jeong JY, Su B, Zhou X. Prognostic significance of postoperative longitudinal change of serum carcinoembryonic antigen level in patients with stage I lung adenocarcinoma completely resected by single-port video-assisted thoracic surgery: a retrospective study. Transl Lung Cancer Res 2021;10:3983-94. [PMID: 34858786 DOI: 10.21037/tlcr-21-833] [Reference Citation Analysis]
4 Qi Y, Wu S, Tao L, Shi Y, Yang W, Zhou L, Zhang B, Li J. Development of Nomograms for Predicting Lymph Node Metastasis and Distant Metastasis in Newly Diagnosed T1-2 Non-Small Cell Lung Cancer: A Population-Based Analysis. Front Oncol 2021;11:683282. [PMID: 34568016 DOI: 10.3389/fonc.2021.683282] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Shen YJ, Qian LQ, Ding ZP, Luo QQ, Zhao H, Xia WY, Fu YY, Feng W, Zhang Q, Yu W, Cai XW, Fu XL. Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection. Front Oncol 2021;11:711206. [PMID: 34540678 DOI: 10.3389/fonc.2021.711206] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zeng H, Huang WW, Liu YJ, Huang Q, Zhao SM, Li YL, Tian PW, Li WM. Development and Validation of a Nomogram for Predicting Prognosis to Immune Checkpoint Inhibitors Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer. Front Oncol 2021;11:685047. [PMID: 34458139 DOI: 10.3389/fonc.2021.685047] [Reference Citation Analysis]
7 Gan J, Fang W, Zhang L. Therapy of lung cancer in China: introducing the special collection. Ther Adv Med Oncol 2021;13:17588359211038199. [PMID: 34413904 DOI: 10.1177/17588359211038199] [Cited by in F6Publishing: 1] [Reference Citation Analysis]